Dentistry's "Liquid Biopsy" Moment: The ADA Convenes Leaders to Chart a Path for Saliva-Based Testing

Dental researchers, clinicians, industry leaders, and other stakeholders gathered at the American Dental Association in Chicago for a summit focused on the potential for saliva-based tools to move from emerging science into routine dental practice.

The meeting, reported by ADA News on July 20, 2026, signals that interest in what saliva can tell us about our health is reaching a new level of seriousness within organized dentistry.

The ADA Salivary Diagnostics Summit, held June 18, drew participants from across dentistry, medicine, research, diagnostics, technology, investment, and insurance to discuss the scientific, regulatory, and clinical steps needed to support broader use of saliva-based testing.

The breadth of that group matters: moving a diagnostic tool from a research setting into everyday dental offices requires alignment not just among scientists, but among insurers, regulators, and the technology industry.

The central question that emerged was not whether saliva has potential to support health and wellness, but how dentistry can develop standards, workflows, evidence-based guidance, and regulatory approval pathways that allow dentists to use salivary testing in a consistent manner.

In other words, the science of reading health signals from saliva is far enough along that the conversation has shifted to the practical "how" rather than the exploratory "whether."

Saliva is no longer viewed merely as a digestive fluid — it contains critical proteins, DNA, RNA, and microbial communities that can reflect a patient's broader health picture.

For patients, this could eventually mean that a routine dental visit does more than check for cavities — it might also flag early warning signs that a dentist can share with a patient's broader care team. That future still requires more standardization and regulatory clarity, but the summit suggests the dental profession is actively working to get there.